Skip to main content
. 2020 May 27;48(5):0300060520926298. doi: 10.1177/0300060520926298

Table 1.

Comparison of general clinical data between the groups.

Urokinase group Urokinase + tirofiban group x2 P
Sex (male/female) 4/3 4/6 0.637
Age (years) 64.71 ± 10.48 58.50 ± 9.03 1.308 0.211
High blood pressure (n/%) 6/85.71 8/80.00 1.000
Diabetes (n/%) 2/28.57 2/20.00 1.000
Blood glucose at admission (mmol/L) 10.43 ± 6.45 8.96 ± 3.51 0.608 0.552
Low density lipoprotein (mmol/L) 2.58 ± 1.12 3.38 ± 0.93 –1.601 0.130
OTT (h) 3.31 ± 0.87 3.05 ± 1.40 0.431 0.673

OTT: onset to treatment time. Qualitative data are expressed as rates and were compared using the chi-squared or Fisher’s exact test; quantitative data were compared using the Mann–Whitney U test.